KELLY MILLS: Open Payments
NPI 1821743626 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $13 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| ABBVIE INC. | 2 | $36 |
| Novo Nordisk Inc | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: The Cologuard Plus Collection Kit, CAPLYTA, VRAYLAR, Rybelsus, SAPIEN 3 Ultra RESILIA, TRINTELLIX, REXULTI, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
